TNF and ulcerative colitis: In this 8.5‐year study of adult patients with ulcerative colitis in Spain, we gathered information on whether patients treated with golimumab were more likely than those treated with other anti‐TNFα therapies to require colon‐removal surgery (‘colectomy’) due to uncontrollable disease or to develop a composite of colon pre‐cancerous lesions and/or colon cancer (‘advanced colonic neoplasia’).